Dallas Matthew D

AVEO Pharmaceuticals, Inc.

Chief Financial Officer

Avg. Two Year Performance

No Purchase Track Record

23% Avg. Sale Return 11% Compound

Holdings: 14.51K shares

Last Three Months: 24-Aug-24 -- 23-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions